🇺🇸 FDA
Patent

US 11945781

Compounds for the treatment of acute and chronic kidney disease

granted A61PA61P13/12

Quick answer

US patent 11945781 (Compounds for the treatment of acute and chronic kidney disease) held by United States Government as represented by the Department of Veterans Affairs expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P13/12